Summary

The surgical imaging market was valued at USD 5.4 million in 2025 and is estimated to reach USD 12.2 million by 2030, registering a CAGR of 17.6% during the forecast period. This is due to the increased use of advanced intraoperative imaging technologies, integration of AI-driven image analysis and augmented reality for surgical navigation, and the expanding installation of hybrid operating rooms in hospitals and outpatient surgical centers. The demand is further boosted by the need for greater surgical precision, shorter procedure times, and better patient outcomes, along with supportive reimbursement policies and ongoing innovations in imaging software and connectivity solutions.

https://www.marketsandmarkets.com/Images/surgical-imaging-market-Overview.webp

“The orthopedic & musculoskeletal surgery segment is estimated to hold the largest share of the surgical imaging market in 2024.”
By application, the orthopedic & musculoskeletal surgery segment is expected to hold the largest share of the surgical imaging market in 2024 due to the high demand for precise, real-time imaging across various orthopedic and musculoskeletal procedures, including knee and hip replacements, scoliosis correction, and complex surgeries. Advanced technologies such as C-arm systems, 3D imaging, and intraoperative CT allow surgeons to accurately position implants, verify bone alignment, and evaluate surgical outcomes immediately, thereby reducing the risk of complications or needing revisions. The increasing number of orthopedic surgeries, driven by sports injuries, traffic accidents, and age-related degenerative conditions, has further boosted the adoption of surgical imaging solutions in this field segment.

“North America accounts for the largest market share in the surgical imaging market in 2024.”
The North American market led the surgical imaging market in 2024. This leadership is driven by factors such as the region’s advanced healthcare infrastructure, high adoption of next-generation intraoperative imaging technologies, and strong integration of AI-powered visualization and data management systems. The growing number of complex surgical procedures in US and Canadian hospitals, along with the rapid growth of hybrid operating rooms equipped with real-time imaging, has further solidified this position. Favorable reimbursement policies, a high concentration of top medical technology companies, and ongoing investments in surgical innovation also support North America’s market leadership.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the surgical imaging marketplace.
The breakdown of primary participants is as mentioned below:
? By Company Type - Tier 1 (48%), Tier 2 (36%), and Tier 3 (16%)
? By Designation ? Directors (15%), Managers (10%), and Others (75%)
? By Region - North America (39%), Europe (31%), the Asia Pacific (21%), and Latin America (6%), and the Middle East & Africa (3%)

Key Players in the Surgical Imaging Market
Prominent players in the surgical imaging market include GE HealthCare (US), Siemens Healthineers AG(Germany), Koninklijke Philips N.V. (Netherlands), Shimadzu Corporation (Japan), Fujifilm Holdings Corporation (Japan), Ziehm Imaging GmbH (Germany), Hologic, Inc. (US), Smith & Nephew (UK), Medtronic (Ireland), United Imaging Healthcare Co. Ltd. (China), Canon Inc. (Japan), Stryker (US), Olympus Corporation (Japan), Novanta Inc. (US), Global Medical (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Sony Electronics Inc. (Japan), Barco (Belgium), Brainlab SE (UK), Auxein (US), Trivitron Healthcare (India), RGS Healthcare (US), GEMSS HEALTHCARE Co., Ltd. (South Korea), Skanray Technologies Limited (India), Nanjing Perlove Medical Equipment Co., Ltd. (China), Arthrex, Inc. (Florida).

Players adopted both organic and inorganic growth strategies, such as product launches and improvements, investments, partnerships, collaborations, joint ventures, funding, acquisitions, expansions, agreements, contracts, and alliances, to increase their offerings, address unmet customer needs, boost profitability, and expand their presence in the global market.

The study features a detailed competitive analysis of major players in the surgical imaging market, including their company profiles, recent updates, and primary market strategies.

Research Coverage
? The report studies the surgical imaging market based on product, brand, application, end user, and region.
? The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
? The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
? The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total surgical imaging market.
? The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.
This report provides insights into the following pointers:
? Analysis of key drivers (technological advancements in surgical imaging modalities, rising demand for minimally invasive surgeries, technological transition to flat-panel detectors and hybrid ORs, expanding applications across surgical specialties), restraints (high equipment costs of surgical imaging systems, interoperability challenges with existing hospital systems, hospital cost cut), opportunities (increasing number of surgical procedures conducted in ambulatory surgical centers, development of hybrid operating rooms, growing demand for data-integrated imaging systems), and challenges (shortage of skilled workforce, imaging obese patients, hospital budget cuts) influencing the industry macrodynamics of surgical imaging market.
? Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the surgical imaging market.
? Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of surgical imaging across regions.
? Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the surgical imaging market.
? Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the surgical imaging market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS 26
1.3 MARKET SCOPE 27
1.3.1 MARKETS AND REGIONS COVERED 27
1.3.2 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 28
1.5 LIMITATIONS 28
1.5.1 METHODOLOGY-RELATED LIMITATIONS 29
1.5.2 SCOPE-RELATED LIMITATIONS 29
1.6 MARKET STAKEHOLDERS 29
1.7 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 32
2.1.1.1 List of secondary sources 32
2.1.2 PRIMARY DATA SOURCES 33
2.1.2.1 List of key primary stakeholders interviewed 33
2.1.2.2 Insights from primary experts 34
2.2 MARKET ESTIMATION METHODOLOGY 35
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 37
2.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION 37
2.2.3 PRIMARY RESEARCH VALIDATION 38
2.3 GROWTH RATE ASSUMPTIONS 39
2.4 DATA TRIANGULATION AND MARKET BREAKDOWN 40
2.5 RESEARCH ASSUMPTIONS 41
2.5.1 STUDY ASSUMPTIONS 41
2.6 RESEARCH LIMITATIONS 41
2.7 RISK ASSESSMENT 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 49
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SURGICAL IMAGING MARKET 49
4.2 ASIA PACIFIC: SURGICAL IMAGING MARKET, BY PRODUCT 50
4.3 SURGICAL IMAGING MARKET, BY KEY COUNTRY/REGION 51
4.4 REGIONAL MIX: SURGICAL IMAGING MARKET 52
4.5 SURGICAL IMAGING MARKET: DEVELOPED VS. EMERGING ECONOMIES 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
5.2.1 DRIVERS 55
5.2.1.1 Technological advancements in surgical imaging modalities 55
5.2.1.2 Rising demand for minimally invasive surgeries 56
5.2.1.3 Technological transition to flat-panel detectors and hybrid operating rooms 56
5.2.1.4 Expanding applications across surgical specialties 57
5.2.2 RESTRAINTS 57
5.2.2.1 High equipment costs of surgical imaging systems 57
5.2.2.2 Interoperability challenges with existing hospital systems 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Increasing number of surgical procedures conducted in ASCs (ambulatory surgical centers) 58
5.2.3.2 Development of hybrid operating rooms (ORs) 58
5.2.3.3 Growing demand for data-integrated imaging systems 58
5.2.4 CHALLENGES 59
5.2.4.1 Shortage of skilled workforce 59
5.2.4.2 Imaging obese patients 59
5.2.4.3 Hospital budget cuts 60
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 60
5.4 INDUSTRY TRENDS 61
5.4.1 INTEGRATION OF ARTIFICIAL INTELLIGENCE AND ADVANCED ANALYTICS 61
5.4.2 AUGMENTED REALITY (AR) AND VIRTUAL REALITY (VR) IN SURGERY 62
5.4.3 GROWTH OF HYBRID OPERATING ROOMS AND MULTIMODAL IMAGING 62
5.4.4 COMPACT, MOBILE, AND LOW-DOSE IMAGING TECHNOLOGIES 62
5.4.5 INTEGRATION WITH SURGICAL ROBOTICS AND ADVANCED 3D/4D IMAGING 62
5.5 PRICING ANALYSIS 63
5.5.1 AVERAGE SELLING PRICE OF SURGICAL IMAGING PRODUCTS, BY TYPE 63
5.5.2 AVERAGE SELLING PRICE OF SURGICAL IMAGING PRODUCTS, BY KEY PLAYER 64
5.5.3 PRICING MODELS 66
5.6 VALUE CHAIN ANALYSIS 67
5.6.1 RESEARCH & DEVELOPMENT 68
5.6.2 MANUFACTURING & ASSEMBLY 68
5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 68
5.7 SUPPLY CHAIN ANALYSIS 69
5.7.1 PROMINENT COMPANIES 69
5.7.2 SMALL & MEDIUM-SIZED ENTERPRISES 69
5.7.3 END USERS 69
?
5.8 ECOSYSTEM ANALYSIS 69
5.9 INVESTMENT AND FUNDING SCENARIO 72
5.10 TECHNOLOGY ANALYSIS 72
5.10.1 KEY TECHNOLOGIES 72
5.10.1.1 Intraoperative imaging systems 72
5.10.1.2 Image-guided surgery and navigation systems 73
5.10.2 COMPLEMENTARY TECHNOLOGIES 73
5.10.2.1 Radiopharmaceutical development and theranostics 73
5.10.2.2 Advanced computing and big data analytics 73
5.10.3 ADJACENT TECHNOLOGIES 73
5.10.3.1 Endoscopic & laparoscopic imaging systems 73
5.10.3.2 AI/Image analytics solutions 74
5.11 PATENT ANALYSIS 74
5.12 TRADE ANALYSIS 77
5.12.1 IMPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022) 78
5.12.2 EXPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022) 79
5.13 KEY CONFERENCES AND EVENTS, 2025?2026 79
5.14 CASE STUDY ANALYSIS 80
5.14.1 ADVANCING ENDOSCOPIC SINUS AND SKULL BASE SURGERY WITH SURGICAL NAVIGATION AT GMCH-32 80
5.14.2 PRECISION MAXILLOFACIAL SURGERY THROUGH BRAINLAB’S INTRAOPERATIVE NAVIGATION AND CT INTEGRATION 81
5.14.3 AI-POWERED REAL-TIME TUMOR MARGIN DETECTION IN SKULL BASE SURGERY WITH STIMULATED RAMAN HISTOLOGY 81
5.15 TARIFF AND REGULATORY LANDSCAPE 82
5.15.1 TARIFF DATA FOR HS CODE 9022 82
5.15.2 REGULATORY LANDSCAPE 83
5.15.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83
5.15.4 REGULATORY TRENDS 85
5.15.4.1 North America 85
5.15.4.1.1 US 85
5.15.4.1.2 Canada 87
5.15.5 EUROPE 88
5.15.6 ASIA PACIFIC 88
5.15.6.1 Japan 88
5.15.6.2 China 89
5.15.6.3 India 91
5.15.6.4 Middle East (GCC Region) 91
5.15.6.4.1 UAE 91
5.15.6.4.2 Saudi Arabia 91
5.15.6.5 Africa 91
?
5.16 REIMBURSEMENT SCENARIO ANALYSIS 92
5.17 PORTER’S FIVE FORCES ANALYSIS 93
5.17.1 BARGAINING POWER OF SUPPLIERS 95
5.17.2 BARGAINING POWER OF BUYERS 95
5.17.3 THREAT OF NEW ENTRANTS 95
5.17.4 THREAT OF SUBSTITUTES 95
5.17.5 INTENSITY OF COMPETITIVE RIVALRY 95
5.18 KEY STAKEHOLDERS AND BUYING CRITERIA 95
5.18.1 KEY STAKEHOLDERS IN BUYING PROCESS 96
5.18.2 BUYING CRITERIA 97
5.19 UNMET NEEDS ANALYSIS 97
5.19.1 CURRENT UNMET NEEDS 97
5.19.2 END-USER EXPECTATIONS 99
5.20 BUSINESS MODEL 100
5.20.1 CAPITAL EQUIPMENT SALES MODEL 100
5.20.2 SUBSCRIPTION AND SAAS MODEL 100
5.20.3 PAY-PER-USE/TRANSACTION-BASED MODEL 100
5.20.4 MANAGED SERVICES MODEL 100
5.20.5 VALUE-BASED/OUTCOME-DRIVEN MODEL 100
5.20.6 HYBRID MODEL (BUNDLED HARDWARE + DIGITAL SERVICES) 100
5.21 IMPACT OF AI/GEN AI ON SURGICAL IMAGING MARKET 101
5.21.1 INTRODUCTION 101
5.21.2 MARKET POTENTIAL OF AI/GEN AI IN SURGICAL IMAGING MARKET 102
5.21.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 103
5.21.3.1 AI-assisted intraoperative imaging for enhanced detection of peritoneal metastases 103
5.21.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 104
5.21.4.1 Surgical navigation & visualization software 104
5.21.4.2 Operating room integration platforms 105
5.21.4.3 Intraoperative imaging systems (CT, MRI, fluoroscopy, ultrasound) 105
5.21.5 USER READINESS AND IMPACT ASSESSMENT 105
5.21.5.1 User readiness 105
5.21.5.1.1 User A: Hospitals 105
5.21.5.1.2 User B: Ambulatory surgical clinics (ASCs) 105
5.21.5.2 Impact assessment 106
5.21.5.2.1 User A: Hospitals 106
5.21.5.2.1.1 Implementation 106
5.21.5.2.1.2 Impact 106
5.21.5.2.2 User B: Ambulatory surgical clinics (ASCs) 106
5.21.5.2.2.1 Implementation 106
5.21.5.2.2.2 Impact 106
?
5.22 IMPACT OF 2025 US TARIFF - OVERVIEW 107
5.22.1 INTRODUCTION 107
5.22.2 KEY TARIFF RATES 107
5.22.3 PRICE IMPACT ANALYSIS 108
5.22.4 IMPACT ON COUNTRY/REGION 109
5.22.4.1 US 109
5.22.4.2 EUROPE 109
5.22.4.3 ASIA PACIFIC 109
5.22.5 IMPACT ON END-USE INDUSTRIES 109
5.22.6 CONCLUSION 110
6 SURGICAL IMAGING MARKET, BY PRODUCT 111
6.1 INTRODUCTION 112
6.2 C-ARMS 112
6.2.1 C-ARMS ENHANCING SURGICAL OUTCOMES THROUGH REAL-TIME FLUOROSCOPIC IMAGING TO DRIVE MARKET 112
6.3 CT SCANNERS 115
6.3.1 ENHANCED OPERATIVE CARE WITH HIGH-ACCURACY INTRAOPERATIVE IMAGING TO DRIVE ADOPTION OF CT SCANNERS 115
6.4 ULTRASOUND SYSTEMS 118
6.4.1 ULTRASOUND ADVANCING SURGICAL PRECISION THROUGH REAL-TIME INTRAOPERATIVE IMAGING TO DRIVE SEGMENTAL GROWTH 118
6.5 INTEGRATED MR-OR SYSTEMS 120
6.5.1 INTEGRATED MR OR SYSTEMS DRIVING SURGICAL ACCURACY THROUGH REAL-TIME SOFT TISSUE IMAGING 120
6.6 SURGICAL NAVIGATION SOFTWARE 123
6.6.1 GROWING USE OF SURGICAL NAVIGATION SOFTWARE DRIVING OPERATIVE PRECISION WITH REAL-TIME GUIDANCE 123
6.7 ACCESSORIES 125
6.7.1 INCREASING ADOPTION OF SURGICAL IMAGING ACCESSORIES TO DRIVE ENHANCED VISUALIZATION AND WORKFLOW EFFICIENCY 125
7 SURGICAL IMAGING MARKET, BY APPLICATION 128
7.1 INTRODUCTION 129
7.2 PROCEDURE TYPE 129
7.2.1 MINIMALLY INVASIVE SURGERY 130
7.2.1.1 Rising adoption of minimally invasive techniques driving precision and faster recovery in surgical imaging 130
7.2.2 LAPAROSCOPY 131
7.2.2.1 Enhanced precision and faster recovery driving increased adoption of laparoscopic imaging 131
7.2.3 ENDOSCOPY 132
7.2.3.1 Real-time internal visualization driving growth in endoscopic imaging 132
7.2.4 OTHER PROCEDURES 133
7.3 SURGERY TYPE 134
7.3.1 GENERAL SURGERY 136
7.3.1.1 Enhanced visualization transforming general surgical procedures to fuel growth 136
7.3.2 CARDIOVASCULAR SURGERY 136
7.3.2.1 Advanced imaging techniques enhancing cardiovascular interventions to fuel growth 136
7.3.3 OB/GYN SURGERY 137
7.3.3.1 Growing use of imaging-guided precision driving improved surgical outcomes in OB/GYN procedures 137
7.3.4 ORTHOPEDIC & MUSCULOSKELETAL SURGERY 138
7.3.4.1 Adoption of imaging solutions driving optimized implant placement and bone alignment 138
7.3.5 NEUROSURGERY 139
7.3.5.1 High-precision imaging navigating complex neural procedures to drive market 139
7.3.6 UROLOGY SURGERY 140
7.3.6.1 Imaging-guided precision improving outcomes in urological surgeries to drive demand 140
7.3.7 OTHER SURGERIES 141
8 SURGICAL IMAGING MARKET, BY END USER 143
8.1 INTRODUCTION 144
8.2 HOSPITALS & SURGICAL CENTERS 144
8.2.1 RISING SURGICAL VOLUMES IN HOSPITALS AND SURGICAL CENTERS TO DRIVE MARKET 144
8.3 SPECIALTY CLINICS 145
8.3.1 SPECIALTY CLINICS DRIVING SURGICAL IMAGING ADOPTION THROUGH PRECISION AND EFFICIENCY 145
8.4 AMBULATORY SURGICAL CENTERS 146
8.4.1 AMBULATORY SURGICAL CENTERS DRIVING SURGICAL IMAGING ADOPTION FOR EFFICIENT OUTPATIENT CARE 146
8.5 OTHER END USERS 147
9 SURGICAL IMAGING MARKET, BY REGION 149
9.1 INTRODUCTION 150
9.2 NORTH AMERICA 151
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 151
9.2.2 US 155
9.2.2.1 Advancements in AI and augmented reality integration in surgery to drive market 155
9.2.3 CANADA 156
9.2.3.1 Collaborations between national AI institutes and health systems to drive market 156
?
9.3 EUROPE 157
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 158
9.3.2 GERMANY 161
9.3.2.1 Precision-driven imaging and expanding hospital capacity to drive regional growth 161
9.3.3 UK 162
9.3.3.1 NHS-led integration of surgical imaging and skilled workforce strength to drive regional growth 162
9.3.4 FRANCE 163
9.3.4.1 Steady growth in radiology workforce supporting imaging expansion 163
9.3.5 ITALY 164
9.3.5.1 Balancing imaging modernization with workforce shortages 164
9.3.6 SPAIN 165
9.3.6.1 Expanding surgical imaging access with focus on regional equity 165
9.3.7 REST OF EUROPE 166
9.4 ASIA PACIFIC 167
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 167
9.4.2 JAPAN 172
9.4.2.1 Enhancing surgical outcomes with innovative imaging technologies 172
9.4.3 CHINA 173
9.4.3.1 Strong network of grade-A tertiary hospitals driving advanced imaging adoption 173
9.4.4 INDIA 174
9.4.4.1 Government initiatives and private hospital collaborations to fuel growth 174
9.4.5 SOUTH KOREA 175
9.4.5.1 Rising aging population driving demand for precision surgical imaging 175
9.4.6 AUSTRALIA 176
9.4.6.1 Strengthening surgical imaging capabilities for minimally invasive procedures 176
9.4.7 REST OF ASIA PACIFIC 177
9.5 LATIN AMERICA 178
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 178
9.5.2 BRAZIL 182
9.5.2.1 Government and private investment in surgical infrastructure to drive market 182
9.5.3 MEXICO 183
9.5.3.1 Accelerating minimally invasive and AI-enabled surgical imaging to drive market 183
9.5.4 REST OF LATIN AMERICA 184
?
9.6 MIDDLE EAST & AFRICA 185
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 185
9.6.2 GCC COUNTRIES 189
9.6.2.1 Rising healthcare demand and innovation driving surgical imaging advancements 189
9.6.3 REST OF MIDDLE EAST & AFRICA 190
10 COMPETITIVE LANDSCAPE 191
10.1 OVERVIEW 191
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 191
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL IMAGING MARKET 192
10.3 REVENUE ANALYSIS, 2020?2024 193
10.4 MARKET SHARE ANALYSIS, 2024 194
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 197
10.5.1 STARS 197
10.5.2 EMERGING LEADERS 197
10.5.3 PERVASIVE PLAYERS 197
10.5.4 PARTICIPANTS 198
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 199
10.5.5.1 Company footprint 199
10.5.5.2 Region footprint 200
10.5.5.3 Product footprint 201
10.5.5.4 Application (procedure type) footprint 202
10.5.5.5 Application (surgery type) footprint 203
10.5.5.6 End-user footprint 204
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 205
10.6.1 PROGRESSIVE COMPANIES 205
10.6.2 RESPONSIVE COMPANIES 205
10.6.3 DYNAMIC COMPANIES 205
10.6.4 STARTING BLOCKS 205
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 207
10.6.5.1 Detailed list of key startups/SMEs 207
10.6.5.2 Competitive benchmarking of emerging players/startups 208
10.7 COMPANY VALUATION & FINANCIAL METRICS 208
10.7.1 FINANCIAL METRICS 208
10.7.2 COMPANY VALUATION 209
10.8 BRAND/PRODUCT COMPARISON 210
10.9 COMPETITIVE SCENARIO 211
10.9.1 PRODUCT LAUNCHES 211
10.9.2 DEALS 212
10.9.3 EXPANSIONS 213
11 COMPANY PROFILES 214
11.1 KEY PLAYERS 214
11.1.1 GE HEALTHCARE 214
11.1.1.1 Business overview 214
11.1.1.2 Products offered 216
11.1.1.3 Recent developments 217
11.1.1.3.1 Product launches & approvals 217
11.1.1.3.2 Deals 219
11.1.1.3.3 Expansions 223
11.1.1.4 MnM view 223
11.1.1.4.1 Right to win 223
11.1.1.4.2 Strategic choices 223
11.1.1.4.3 Weaknesses & competitive threats 224
11.1.2 SIEMENS HEALTHINEERS AG 225
11.1.2.1 Business overview 225
11.1.2.2 Products offered 227
11.1.2.3 Recent developments 229
11.1.2.3.1 Product launches & approvals 229
11.1.2.3.2 Deals 231
11.1.2.3.3 Other developments 232
11.1.2.3.4 Expansions 232
11.1.2.4 MnM view 233
11.1.2.4.1 Right to win 233
11.1.2.4.2 Strategic choices 233
11.1.2.4.3 Weaknesses & competitive threats 233
11.1.3 KONINKLIJKE PHILIPS N.V. 234
11.1.3.1 Business overview 234
11.1.3.2 Products offered 236
11.1.3.3 Recent developments 237
11.1.3.3.1 Product launches & approvals 237
11.1.3.3.2 Deals 239
11.1.3.4 MnM view 240
11.1.3.4.1 Right to win 240
11.1.3.4.2 Strategic choices 240
11.1.3.4.3 Weaknesses & competitive threats 240
11.1.4 SHIMADZU CORPORATION 241
11.1.4.1 Business overview 241
11.1.4.2 Products offered 243
11.1.4.3 Recent developments 244
11.1.4.3.1 Product launches & approvals 244
11.1.4.3.2 Deals 245
?
11.1.4.4 MnM view 245
11.1.4.4.1 Right to win 245
11.1.4.4.2 Strategic choices 245
11.1.4.4.3 Weaknesses & competitive threats 246
11.1.5 FUJIFILM HOLDINGS CORPORATION 247
11.1.5.1 Business overview 247
11.1.5.2 Products offered 249
11.1.5.3 Recent developments 250
11.1.5.3.1 Product launches & approvals 250
11.1.5.3.2 Deals 250
11.1.5.4 MnM view 251
11.1.5.4.1 Right to win 251
11.1.5.4.2 Strategic choices 251
11.1.5.4.3 Weaknesses & competitive threats 252
11.1.6 ZIEHM IMAGING GMBH 253
11.1.6.1 Business overview 253
11.1.6.2 Products offered 253
11.1.6.3 Recent developments 255
11.1.6.3.1 Product launches & approvals 255
11.1.6.3.2 Deals 255
11.1.7 HOLOGIC, INC. 256
11.1.7.1 Business overview 256
11.1.7.2 Products offered 258
11.1.7.3 Recent developments 259
11.1.7.3.1 Deals 259
11.1.8 SMITH+NEPHEW 260
11.1.8.1 Business overview 260
11.1.8.2 Products offered 261
11.1.8.3 Recent developments 262
11.1.8.3.1 Product launches & approvals 262
11.1.8.3.2 Deals 262
11.1.9 MEDTRONIC 263
11.1.9.1 Business overview 263
11.1.9.2 Products offered 264
11.1.9.3 Recent developments 266
11.1.9.3.1 Product launches & approvals 266
11.1.9.3.2 Deals 266
11.1.10 STRYKER 267
11.1.10.1 Business overview 267
11.1.10.2 Products offered 268
11.1.10.3 Recent developments 269
11.1.10.3.1 Product launches & approvals 269
11.1.10.3.2 Deals 269
11.1.11 CANON MEDICAL SYSTEMS CORPORATION 270
11.1.11.1 Business overview 270
11.1.11.2 Products offered 272
11.1.11.3 Recent developments 273
11.1.11.3.1 Product launches & approvals 273
11.1.11.3.2 Deals 273
11.1.12 OLYMPUS CORPORATION 274
11.1.12.1 Business overview 274
11.1.12.2 Products offered 275
11.1.12.3 Recent developments 275
11.1.12.3.1 PRODUCT LAUNCHES AND APPROVALS 276
11.1.12.3.2 Deals 276
11.1.12.3.3 Expansions 276
11.1.13 NOVANTA INC. 277
11.1.13.1 Business overview 277
11.1.13.2 Products offered 279
11.1.13.3 Recent developments 279
11.1.13.3.1 Deals 279
11.1.14 GLOBUS MEDICAL 280
11.1.14.1 Business overview 280
11.1.14.2 Products offered 281
11.1.14.3 Recent developments 282
11.1.14.3.1 Product launches & approvals 282
11.1.14.3.2 Deals 282
11.1.15 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 283
11.1.15.1 Business overview 283
11.1.15.2 Products offered 285
11.1.15.3 Recent developments 286
11.1.15.3.1 Product launches & approvals 286
11.1.16 SONY ELECTRONICS INC. 287
11.1.16.1 Business overview 287
11.1.16.2 Products offered 287
11.1.16.3 Recent developments 288
11.1.16.3.1 Product launches & approvals 288
11.1.16.3.2 Deals 288
11.1.17 UNITED IMAGING HEALTHCARE CO., LTD. 289
11.1.17.1 Business overview 289
11.1.17.2 Products offered 290
11.1.17.3 Recent developments 290
11.1.17.3.1 Product launches & approvals 290
?
11.1.18 BARCO 291
11.1.18.1 Business overview 291
11.1.18.2 Products offered 292
11.1.18.3 Recent developments 293
11.1.18.3.1 Product launches & approvals 293
11.1.18.3.2 Deals 293
11.1.19 AUXEIN 294
11.1.19.1 Business overview 294
11.1.19.2 Products offered 295
11.1.19.3 Recent developments 295
11.1.19.3.1 Product launches & approvals 295
11.1.20 BRAINLAB SE 296
11.1.20.1 Business overview 296
11.1.20.2 Products offered 296
11.1.20.3 Recent developments 297
11.1.20.3.1 Deals 297
11.2 OTHER PLAYERS 298
11.2.1 TRIVITRON HEALTHCARE 298
11.2.2 RGS HEALTHCARE 299
11.2.3 GEMSS HEALTHCARE CO., LTD. 300
11.2.4 SKANRAY TECHNOLOGIES LIMITED 301
11.2.5 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD. 302
11.2.6 ARTHREX, INC. 303
12 APPENDIX 304
12.1 DISCUSSION GUIDE 304
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 308
12.3 CUSTOMIZATION OPTIONS 310
12.4 RELATED REPORTS 310
12.5 AUTHOR DETAILS 311

ページTOPに戻る

List of Tables/Graphs

TABLE 1 SURGICAL IMAGING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 55
TABLE 2 AVERAGE SELLING PRICE OF TOP PRODUCTS, BY KEY PLAYER, 2024 64
TABLE 3 AVERAGE SELLING PRICE TREND OF SURGICAL IMAGING PRODUCTS,
BY REGION, 2022?2024 65
TABLE 4 SURGICAL IMAGING MARKET: ROLE OF COMPANIES IN ECOSYSTEM 71
TABLE 5 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR SURGICAL IMAGING MARKET (2025) 75
TABLE 6 IMPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022),
BY COUNTRY, 2020?2024 (USD THOUSAND) 78
TABLE 7 EXPORT DATA FOR SURGICAL IMAGING PRODUCTS (HS CODE 9022),
BY COUNTRY, 2020?2024 (USD THOUSAND) 79
TABLE 8 SURGICAL IMAGING MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS, 2025?2026 79
TABLE 9 TARIFF DATA FOR HS CODE 9022 82
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 84
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 85
TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 15 US FDA: MEDICAL DEVICE CLASSIFICATION 86
TABLE 16 US: APPROVED IMAGING DEVICES BY FDA 86
TABLE 17 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 87
TABLE 18 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 87
TABLE 19 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 89
TABLE 20 CHINA: CLASSIFICATION OF MEDICAL DEVICES 89
TABLE 21 MEDICAL REIMBURSEMENT CPT CODES FOR SURGICAL PROCEDURES IN US, 2025 92
TABLE 22 SURGICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 93
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 96
TABLE 24 KEY BUYING CRITERIA FOR END USERS 97
TABLE 25 UNMET NEEDS IN SURGICAL IMAGING MARKET 98
TABLE 26 END-USER EXPECTATIONS IN SURGICAL IMAGING MARKET 99
TABLE 27 US ADJUSTED RECIPROCAL TARIFF RATES (AS OF AUGUST 2025) 107
TABLE 28 SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 112
TABLE 29 C-ARMS SURGICAL IMAGING MARKET, BY OFFERINGS OF MAJOR PLAYERS 113
TABLE 30 C-ARMS: SURGICAL IMAGING MARKET, BY REGION, 2023?2030 (USD MILLION) 113
TABLE 31 C-ARMS: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 114
TABLE 32 C-ARMS: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE),
2023?2030 (USD MILLION) 114
TABLE 33 C-ARMS: SURGICAL IMAGING MARKET, BY END USER, 2023?2030 (USD MILLION) 115
TABLE 34 CT SCANNERS: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 116
TABLE 35 CT SCANNERS: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 116
TABLE 36 CT SCANNERS: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023?2030 (USD MILLION) 117
TABLE 37 CT SCANNERS: SURGICAL IMAGING MARKET, BY END USER,
2023?2030 (USD MILLION) 117
TABLE 38 ULTRASOUND SYSTEMS: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 118
TABLE 39 ULTRASOUND SYSTEMS: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 119
TABLE 40 ULTRASOUND SYSTEMS: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023?2030 (USD MILLION) 119
TABLE 41 ULTRASOUND SYSTEMS: SURGICAL IMAGING MARKET, BY END USER,
2023?2030 (USD MILLION) 120
TABLE 42 INTEGRATED MR-OR SYSTEMS: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 121
TABLE 43 INTEGRATED MR-OR SYSTEMS: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 121
TABLE 44 INTEGRATED MR-OR SYSTEMS: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE, 2023?2030 (USD MILLION) 122
TABLE 45 INTEGRATED MR-OR SYSTEMS: SURGICAL IMAGING MARKET, BY END USER, 2023?2030 (USD MILLION) 122
TABLE 46 SURGICAL NAVIGATION SOFTWARE: SURGICAL IMAGING MARKET, BY REGION, 2023?2030 (USD MILLION) 123
TABLE 47 SURGICAL NAVIGATION SOFTWARE: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 124
TABLE 48 SURGICAL NAVIGATION SOFTWARE: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023?2030 (USD MILLION) 124
TABLE 49 SURGICAL NAVIGATION SOFTWARE: SURGICAL IMAGING MARKET,
BY END USER, 2023?2030 (USD MILLION) 125
TABLE 50 ACCESSORIES: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 126
TABLE 51 ACCESSORIES: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 126
TABLE 52 ACCESSORIES: SURGICAL IMAGING MARKET, BY APPLICATION
(SURGERY TYPE), 2023?2030 (USD MILLION) 127
TABLE 53 ACCESSORIES: SURGICAL IMAGING MARKET, BY END USER,
2023?2030 (USD MILLION) 127
TABLE 54 SURGICAL IMAGING MARKET, BY PROCEDURE TYPE, 2023?2030 (USD MILLION) 129
TABLE 55 PROCEDURE TYPE: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 130
TABLE 56 MINIMALLY INVASIVE SURGERY: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 131
TABLE 57 LAPAROSCOPY: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 132
TABLE 58 ENDOSCOPY: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 133
TABLE 59 OTHER PROCEDURES: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 134
TABLE 60 SURGICAL IMAGING MARKET, BY SURGERY TYPE, 2023?2030 (USD MILLION) 135
TABLE 61 SURGERY TYPE: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 135
TABLE 62 GENERAL SURGERY: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 136
TABLE 63 CARDIOVASCULAR SURGERY: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 137
TABLE 64 OB/GYN SURGERY: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 138
TABLE 65 ORTHOPEDIC & MUSCULOSKELETAL SURGERY: SURGICAL IMAGING MARKET,
BY REGION, 2023?2030 (USD MILLION) 139
TABLE 66 NEUROSURGERY: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 140
TABLE 67 UROLOGY SURGERY: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 141
TABLE 68 OTHER SURGERIES: SURGICAL IMAGING MARKET, BY REGION,
2023?2030 (USD MILLION) 142
TABLE 69 SURGICAL IMAGING MARKET, BY END USER, 2023?2030 (USD MILLION) 144
TABLE 70 SURGICAL IMAGING MARKET FOR HOSPITALS & SURGICAL CENTERS,
BY REGION, 2023?2030 (USD MILLION) 145
TABLE 71 SURGICAL IMAGING MARKET FOR SPECIALTY CLINICS, BY REGION,
2023?2030 (USD MILLION) 146
TABLE 72 SURGICAL IMAGING MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2023?2030 (USD MILLION) 147
TABLE 73 SURGICAL IMAGING MARKET FOR OTHER END USERS, BY REGION,
2023?2030 (USD MILLION) 148
TABLE 74 SURGICAL IMAGING MARKET, BY REGION, 2023?2030 (USD MILLION) 150
TABLE 75 NORTH AMERICA: MACROECONOMIC OUTLOOK 152
TABLE 76 NORTH AMERICA: SURGICAL IMAGING MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 153
TABLE 77 NORTH AMERICA: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 153
TABLE 78 NORTH AMERICA: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 154
TABLE 79 NORTH AMERICA: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023?2030 (USD MILLION) 154
TABLE 80 NORTH AMERICA: SURGICAL IMAGING MARKET, BY END USER,
2023?2030 (USD MILLION) 155
TABLE 81 US: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 156
TABLE 82 CANADA: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 157
TABLE 83 EUROPE: MACROECONOMIC OUTLOOK 158
TABLE 84 EUROPE: SURGICAL IMAGING MARKET, BY COUNTRY, 2023?2030 (USD MILLION) 159
TABLE 85 EUROPE: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 159
TABLE 86 EUROPE: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 160
TABLE 87 EUROPE: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE),
2023?2030 (USD MILLION) 160
TABLE 88 EUROPE: SURGICAL IMAGING MARKET, BY END USER, 2023?2030 (USD MILLION) 161
TABLE 89 GERMANY: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 162
TABLE 90 UK: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 163
TABLE 91 FRANCE: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 164
TABLE 92 ITALY: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 165
TABLE 93 SPAIN: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 166
TABLE 94 REST OF EUROPE: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 167
TABLE 95 ASIA PACIFIC: MACROECONOMIC OUTLOOK 168
TABLE 96 ASIA PACIFIC: SURGICAL IMAGING MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 170
TABLE 97 ASIA PACIFIC: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 170
TABLE 98 ASIA PACIFIC: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 171
TABLE 99 ASIA PACIFIC: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023?2030 (USD MILLION) 171
TABLE 100 ASIA PACIFIC: SURGICAL IMAGING MARKET, BY END USER,
2023?2030 (USD MILLION) 172
TABLE 101 JAPAN: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 173
TABLE 102 CHINA: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 174
TABLE 103 INDIA: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 175
TABLE 104 SOUTH KOREA: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 176
TABLE 105 AUSTRALIA: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 177
TABLE 106 REST OF ASIA PACIFIC: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 178
TABLE 107 LATIN AMERICA: MACROECONOMIC OUTLOOK 179
TABLE 108 LATIN AMERICA: SURGICAL IMAGING MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 179
TABLE 109 LATIN AMERICA: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 180
TABLE 110 LATIN AMERICA: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 180
TABLE 111 LATIN AMERICA: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023?2030 (USD MILLION) 181
TABLE 112 LATIN AMERICA: SURGICAL IMAGING MARKET, BY END USER,
2023?2030 (USD MILLION) 181
TABLE 113 BRAZIL: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 182
TABLE 114 MEXICO: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 183
TABLE 115 REST OF LATIN AMERICA: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 184
TABLE 116 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 186
TABLE 117 MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY COUNTRY,
2023?2030 (USD MILLION) 186
TABLE 118 MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 187
TABLE 119 MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE), 2023?2030 (USD MILLION) 187
TABLE 120 MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2023?2030 (USD MILLION) 188
TABLE 121 MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY END USER,
2023?2030 (USD MILLION) 188
TABLE 122 GCC COUNTRIES: SURGICAL IMAGING MARKET, BY PRODUCT,
2023?2030 (USD MILLION) 189
TABLE 123 REST OF MIDDLE EAST & AFRICA: SURGICAL IMAGING MARKET, BY PRODUCT, 2023?2030 (USD MILLION) 190
TABLE 124 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SURGICAL IMAGING MARKET, JANUARY 2022?AUGUST 2025 192
TABLE 125 SURGICAL IMAGING MARKET: DEGREE OF COMPETITION 195
TABLE 126 SURGICAL IMAGING MARKET: REGION FOOTPRINT 200
TABLE 127 SURGICAL IMAGING MARKET: PRODUCT FOOTPRINT 201
TABLE 128 SURGICAL IMAGING MARKET: APPLICATION (PROCEDURE TYPE) FOOTPRINT 202
TABLE 129 SURGICAL IMAGING MARKET: APPLICATION (SURGERY TYPE) FOOTPRINT 203
TABLE 130 SURGICAL IMAGING MARKET: END-USER FOOTPRINT 204
TABLE 131 SURGICAL IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 207
TABLE 132 SURGICAL IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS 208
TABLE 133 SURGICAL IMAGING MARKET: PRODUCT LAUNCHES,
JANUARY 2022?AUGUST 2025 211
TABLE 134 SURGICAL IMAGING MARKET: DEALS, JANUARY 2022?AUGUST 2025 212
TABLE 135 SURGICAL IMAGING MARKET: EXPANSIONS, JANUARY 2022?AUGUST 2025 213
TABLE 136 GE HEALTHCARE: COMPANY OVERVIEW 214
TABLE 137 GE HEALTHCARE: PRODUCTS OFFERED 216
TABLE 138 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?AUGUST 2025 217
TABLE 139 GE HEALTHCARE: DEALS, JANUARY 2022?AUGUST 2025 219
TABLE 140 GE HEALTHCARE: EXPANSIONS, JANUARY 2022?AUGUST 2025 223
TABLE 141 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 225
TABLE 142 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 227
TABLE 143 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?AUGUST 2025 229
TABLE 144 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022?AUGUST 2025 231
TABLE 145 SIEMENS HEALTHINEERS AG: OTHER DEVELOPMENTS,
JANUARY 2022?AUGUST 2025 232
TABLE 146 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022?AUGUST 2025 232
TABLE 147 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 234
TABLE 148 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 236
TABLE 149 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?AUGUST 2025 237
TABLE 150 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022?AUGUST 2025 239
TABLE 151 SHIMADZU CORPORATION: COMPANY OVERVIEW 241
TABLE 152 SHIMADZU CORPORATION: PRODUCTS OFFERED 243
TABLE 153 SHIMADZU CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?AUGUST 2025 244
TABLE 154 SHIMADZU CORPORATION: DEALS, JANUARY 2022?AUGUST 2025 245
TABLE 155 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW 247
TABLE 156 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 249
TABLE 157 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?AUGUST 2025 250
TABLE 158 FUJIFILM HOLDINGS CORPORATION: DEALS, JANUARY 2022?AUGUST 2025 250
TABLE 159 ZIEHM IMAGING GMBH: COMPANY OVERVIEW 253
TABLE 160 ZIEHM IMAGING GMBH: PRODUCTS OFFERED 253
TABLE 161 ZIEHM IMAGING GMBH: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?AUGUST 2025 255
TABLE 162 ZIEHM IMAGING GMBH: DEALS, JANUARY 2022?AUGUST 2025 255
TABLE 163 HOLOGIC, INC.: COMPANY OVERVIEW 256
TABLE 164 HOLOGIC, INC.: PRODUCTS OFFERED 258
TABLE 165 HOLOGIC, INC.: DEALS, JANUARY 2022?AUGUST 2025 259
TABLE 166 SMITH+NEPHEW: COMPANY OVERVIEW 260
TABLE 167 SMITH+NEPHEW: PRODUCTS OFFERED 261
TABLE 168 SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?AUGUST 2025 262
TABLE 169 SMITH+NEPHEW: DEALS, JANUARY 2022?AUGUST 2025 262
TABLE 170 MEDTRONIC: COMPANY OVERVIEW 263
TABLE 171 MEDTRONIC: PRODUCTS OFFERED 264
TABLE 172 MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?AUGUST 2025 266
TABLE 173 MEDTRONIC: DEALS, JANUARY 2022?AUGUST 2025 266
TABLE 174 STRYKER: COMPANY OVERVIEW 267
TABLE 175 STRYKER: PRODUCTS OFFERED 268
TABLE 176 STRYKER: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?AUGUST 2025 269
TABLE 177 STRYKER: DEALS, JANUARY 2022?AUGUST 2025 269
TABLE 178 CANON INC.: COMPANY OVERVIEW 270
TABLE 179 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 272
TABLE 180 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?AUGUST 2025 273
TABLE 181 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022?AUGUST 2025 273
TABLE 182 OLYMPUS CORPORATION: COMPANY OVERVIEW 274
TABLE 183 OLYMPUS CORPORATION: PRODUCTS OFFERED 275
TABLE 184 OLYMPUS CORPORATION: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022?AUGUST 2025 276
TABLE 185 OLYMPUS CORPORATION: DEALS, JANUARY 2022?AUGUST 2025 276
TABLE 186 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2022?AUGUST 2025 276
TABLE 187 NOVANTA INC.: COMPANY OVERVIEW 277
TABLE 188 NOVANTA INC.: PRODUCTS OFFERED 279
TABLE 189 NOVANTA INC.: DEALS, JANUARY 2022?AUGUST 2025 279
TABLE 190 GLOBUS MEDICAL: COMPANY OVERVIEW 280
TABLE 191 GLOBUS MEDICAL: PRODUCTS OFFERED 281
TABLE 192 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?AUGUST 2025 282
TABLE 193 GLOBUS MEDICAL: DEALS, JANUARY 2022?AUGUST 2025 282
TABLE 194 SHENZHEN MINDRAY: COMPANY OVERVIEW 283
TABLE 195 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 285
TABLE 196 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?AUGUST 2025 286
TABLE 197 SONY ELECTRONICS INC.: COMPANY OVERVIEW 287
TABLE 198 SONY ELECTRONICS INC.: PRODUCTS OFFERED 287
TABLE 199 SONY ELECTRONICS INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022?MAY 2025 288
TABLE 200 SONY ELECTRONICS INC: DEALS, JANUARY 2022?AUGUST 2025 288
TABLE 201 UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY OVERVIEW 289
TABLE 202 UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCTS OFFERED 290
TABLE 203 UNITED IMAGING HEALTHCARE CO., LTD.: PRODUCT LAUNCHES &
APPROVALS, JANUARY 2022?AUGUST 2025 290
TABLE 204 BARCO: COMPANY OVERVIEW 291
TABLE 205 BARCO: PRODUCTS OFFERED 292
TABLE 206 BARCO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?AUGUST 2025 293
TABLE 207 BARCO: DEALS, JANUARY 2022?AUGUST 2025 293
TABLE 208 AUXEIN: COMPANY OVERVIEW 294
TABLE 209 AUXEIN: PRODUCTS OFFERED 295
TABLE 210 AUXEIN: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022?AUGUST 2025 295
TABLE 211 BRAINLAB SE: COMPANY OVERVIEW 296
TABLE 212 BRAINLAB SE: PRODUCTS OFFERED 296
TABLE 213 BRAINLAB SE: DEALS, JANUARY 2022?AUGUST 2025 297
TABLE 214 TRIVITRON HEALTHCARE: COMPANY OVERVIEW 298
TABLE 215 RGS HEALTHCARE: COMPANY OVERVIEW 299
TABLE 216 GEMSS HEALTHCARE CO., LTD.: COMPANY OVERVIEW 300
TABLE 217 SKANRAY TECHNOLOGIES LIMITED: COMPANY OVERVIEW 301
TABLE 218 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW 302
TABLE 219 ARTHREX, INC.: COMPANY OVERVIEW 303FIGURE 1 MARKET AND REGIONAL SEGMENTATION 27
FIGURE 2 SURGICAL IMAGING MARKET: RESEARCH DESIGN 31
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 35
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 36
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 6 SURGICAL IMAGING MARKET: BOTTOM-UP APPROACH 38
FIGURE 7 CAGR PROJECTIONS 39
FIGURE 8 DATA TRIANGULATION METHODOLOGY 40
FIGURE 9 SURGICAL IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 43
FIGURE 10 SURGICAL IMAGING MARKET, BY APPLICATION (PROCEDURE TYPE),
2025 VS. 2030 44
FIGURE 11 SURGICAL IMAGING MARKET, BY APPLICATION (SURGERY TYPE), 2025 VS. 2030 45
FIGURE 12 SURGICAL IMAGING MARKET, BY END USER, 2025 VS. 2030 46
FIGURE 13 SURGICAL IMAGING MARKET: REGIONAL SNAPSHOT 47
FIGURE 14 GROWING DEMAND FOR MINIMALLY INVASIVE SURGERIES AND ADVANCEMENTS IN INTRAOPERATIVE IMAGING TO DRIVE MARKET 49
FIGURE 15 C-ARMS SEGMENT AND JAPAN TO COMMAND LARGEST SHARES OF ASIA PACIFIC MARKET IN 2024 50
FIGURE 16 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 51
FIGURE 17 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 52
FIGURE 18 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 53
FIGURE 19 SURGICAL IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS IN SURGICAL IMAGING MARKET 61
FIGURE 21 AVERAGE SELLING PRICE TREND OF SURGICAL IMAGING PRODUCTS,
BY TYPE, 2024 63
FIGURE 22 AVERAGE SELLING PRICE TREND OF SURGICAL IMAGING PRODUCTS,
BY KEY PLAYER, 2024 64
FIGURE 23 AVERAGE SELLING PRICE TREND OF SURGICAL IMAGING PRODUCTS,
BY REGION, 2024 65
FIGURE 24 SURGICAL IMAGING MARKET: VALUE CHAIN ANALYSIS 68
FIGURE 25 SURGICAL IMAGING MARKET: SUPPLY CHAIN ANALYSIS 69
FIGURE 26 SURGICAL IMAGING MARKET: ECOSYSTEM ANALYSIS 70
FIGURE 27 INVESTMENT AND FUNDING SCENARIO 72
FIGURE 28 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR SURGICAL IMAGING MARKET (2025) 75
FIGURE 29 SURGICAL IMAGING MARKET: TOP PATENT OWNERS/PATENTING TRENDS,
2015?2025 77
FIGURE 30 SURGICAL IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 94
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 96
FIGURE 32 KEY BUYING CRITERIA FOR END USERS 97
FIGURE 33 MARKET POTENTIAL OF AI/GEN AI ON SURGICAL IMAGING ACROSS INDUSTRIES 102
FIGURE 34 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 104
FIGURE 35 NORTH AMERICA: SURGICAL IMAGING MARKET SNAPSHOT, 2024 152
FIGURE 36 ASIA PACIFIC: SURGICAL IMAGING MARKET SNAPSHOT, 2024 169
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SURGICAL IMAGING MARKET,
2020?2024 194
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN SURGICAL IMAGING MARKET, 2024 195
FIGURE 39 SURGICAL IMAGING MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 198
FIGURE 40 SURGICAL IMAGING MARKET: COMPANY FOOTPRINT 199
FIGURE 41 SURGICAL IMAGING MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 206
FIGURE 42 EV/EBITDA OF KEY VENDORS 208
FIGURE 43 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK
BETA OF KEY VENDORS 209
FIGURE 44 SURGICAL IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 210
FIGURE 45 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 215
FIGURE 46 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 226
FIGURE 47 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 235
FIGURE 48 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 242
FIGURE 49 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2024) 248
FIGURE 50 HOLOGIC, INC.: COMPANY SNAPSHOT (2024) 257
FIGURE 51 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 261
FIGURE 52 MEDTRONIC: COMPANY SNAPSHOT (2024) 264
FIGURE 53 STRYKER: COMPANY SNAPSHOT (2024) 268
FIGURE 54 CANON INC.: COMPANY SNAPSHOT (2024) 271
FIGURE 55 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2024) 275
FIGURE 56 NOVANTA INC.: COMPANY SNAPSHOT (2024) 278
FIGURE 57 GLOBUS MEDICAL: COMPANY SNAPSHOT (2024) 281
FIGURE 58 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2024) 284
FIGURE 59 UNITED IMAGING HEALTHCARE CO., LTD.: COMPANY SNAPSHOT (2024) 289
FIGURE 60 BARCO: COMPANY SNAPSHOT (2024) 292